Regenerative Medical Technology Group Inc. (RMTG)

Market Cap	515.05K +14.5%
Revenue (ttm)	5.04M +56.9%
Net Income	-7.06M
EPS	-0.56
Shares Out	13.14M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Average Volume	15,837
Open	0.0400
Previous Close	0.0390
Day's Range	0.0400 - 0.0400
52-Week Range	0.0223 - 0.0786
Beta	0.77
RSI	46.08
Earnings Date	Apr 14, 2026

About RMTG

Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its process using its kits and solutions. The company was formerly known as Meso ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: RMTG

Financial Performance

In 2024, RMTG's revenue was $4.11 million, an increase of 70.44% compared to the previous year's $2.41 million. Losses were -$5.56 million, -43.31% less than in 2023.